Related by context. All words. (Click for frequent words.) 76 Meets Primary Endpoint 74 Cypher Sirolimus 74 Patients Treated With 73 Phase III Clinical Trial 73 Prospective Randomized 73 Completes Enrollment 73 Combo Stent 73 Randomized Clinical Trial 73 Oral Fingolimod 73 Completes Patient Enrollment 73 Clinical Trial Results 73 Study Evaluating 72 FDA Approvals 72 Phase 2a Clinical Trial 72 Medoxomil 72 Initiates Enrollment 72 Pivotal Trial 72 Receives Orphan Drug Designation 72 Phase 2b Clinical Trial 72 Prolongs Survival 72 Eluting Coronary Stent System 72 Patient Enrollment 72 NAVISTAR R 71 Pivotal Study 71 Phase 2b Trial 71 Investigational Compound 71 Initiates Clinical Trial 71 Phase III Trial 71 Dose Ranging Study 71 Unfractionated Heparin 71 Kinase Inhibitor 71 Severe Sepsis 71 Demonstrates Positive 71 Preclinical Study 71 Tezampanel 71 Drug Candidate 71 Bazedoxifene 71 Novel Oral 71 Pivotal Phase III 71 By JENNIFER LEARN 71 Improves Survival 70 Initiates Phase II 70 Autologous Stem Cell Transplantation 70 lexidronam injection 70 Stent Thrombosis 70 bevacizumab Avastin R 70 Pooled Analysis 70 Phase IIb Clinical Trial 70 Demonstrates Sustained 70 Zorbtive TM 70 Presents Preclinical Data 70 First Patient Treated 70 Phase IIb Trial 70 Expanded Indication 70 Investigational Treatment 70 Initiate Clinical Trial 70 Antitumor Activity 70 Acute Ischemic Stroke 70 Shows Promising 70 Combination REOLYSIN R 70 Drug Eluting 70 JAK Inhibitor 70 Adjuvant Treatment 70 Initiates Clinical 70 Files IND 70 NDA Submission 70 Controlled Trial 70 5 FU leucovorin 69 Single Dose 69 Hormone Refractory Prostate Cancer 69 II Clinical Trial 69 Hsp# Inhibitor 69 Sirolimus eluting Coronary Stent 69 Novel Inhibitor 69 Long Term Efficacy 69 Pivotal Phase 69 R Saizen R 69 Systemic Delivery 69 Regenerative Cells 69 Granted Orphan Drug 69 Patients Undergoing 69 Clinical Outcome 69 Anticancer Drug 69 Trial Evaluating 69 Aneurysm Repair 69 Randomized Evaluation 69 Patients Enrolled 69 Preclinical Data 69 Proc Am Soc 69 Peginterferon 69 Metastatic Melanoma 69 Relapsing Multiple Sclerosis 69 Chronic Hepatitis C 69 Pivotal Clinical Trial 69 bevacizumab Avastin ® 69 Survival Benefit 69 Intravitreal 69 Acute Myocardial Infarction 69 familial amyloidotic polyneuropathy FAP 69 First Patient Dosed 69 Announces FDA Clearance 69 Complicated Skin 69 Demonstrates Significant 69 Multicenter Randomized 69 PROMUS R 68 Low Dose 68 Ranolazine 68 Infarct 68 Randomized Phase 68 TO AVOID PREGNANCY WHILE 68 Improves Outcomes 68 First Patient Enrolled 68 Initiates Clinical Trials 68 Hepatocellular Carcinoma 68 R lenalidomide 68 Nilotinib 68 Glufosfamide 68 Anti Tumor 68 Randomized Study 68 Initiates Phase III 68 Platelet Inhibition 68 Embolic Protection 68 evaluating tivozanib 68 TAXUS Element Paclitaxel Eluting 68 Ovitrelle R Serostim 68 Aflibercept 68 Bucindolol 68 candesartan cilexetil 68 Bivalirudin 68 Initiate Phase III 68 Transdermal Patch 68 Adjuvant Chemotherapy 68 Clinical Trial Evaluating 68 Heart Failure Patients 68 catheter occlusion 68 Cardiotoxicity 68 Factor VIIa 68 Drug Eluting Coronary Stent 68 pan HDAC inhibitor 68 fosbretabulin 68 Mylan Receives Approval 68 Percutaneous Transluminal Coronary Angioplasty 68 Aliskiren 68 acute peripheral arterial 68 Renal Cell Carcinoma 68 Humanized Anti 68 Phase Ib Clinical Trial 68 FDA APPROVES 68 Demonstrates Potent 68 Recombinant Human 68 Teva Provides Update 68 cetuximab Erbitux R 68 Patients Treated 68 ISTODAX ® 68 Antitumor 68 Neoadjuvant Chemotherapy 68 metastatic malignant 68 topically applied SEPA 68 PRN FDA Approves 68 HER2 Positive Breast Cancer 68 REMINDER ORLive Presents 68 See CLINICAL PHARMACOLOGY 68 Phase 2a Trial 68 somatostatin analog 68 Placebo Controlled Trial 68 Chronic Heart Failure 67 Contrast Agent 67 Paclitaxel Eluting 67 Controlled Study 67 Renal Artery 67 Newly Diagnosed Multiple Myeloma 67 samarium Sm 67 cisplatin gemcitabine 67 Antigen Specific 67 Drug Prevents 67 occlusion PAO 67 TRANSDUR ™ 67 Parathyroid Hormone 67 ALN HPN 67 BCG refractory carcinoma 67 Phase III Pivotal 67 investigational pharmacologically unique 67 Well Tolerated 67 FDA Clears 67 Submits NDA 67 thalidomide Thalomid 67 FDA Accepts 67 Vicriviroc 67 FDA Okays 67 Gets FDA Clearance 67 Ischemic 67 ORLive Presents 67 Peginterferon Alfa 2a 67 Fondaparinux 67 sorafenib Nexavar 67 Sirolimus Eluting Stent 67 Hypertensive Patients 67 Neoadjuvant 67 TAXUS ® 67 Receives Approvable Letter 67 TM Everolimus Eluting 67 Syncria R 67 Presents Positive 67 5 fluorouracil leucovorin 67 CYPHER R Sirolimus Eluting 67 Treatment Naïve 67 Degarelix 67 Coronary Stent 67 Gastric Cancer 67 MKC# MKC# PP 67 Mg Usa 67 Kidney Transplant Patients 67 Intravascular 67 TAXUS TM 67 J Am Coll 67 Bosutinib 67 Initiate Phase 67 JAK2 Inhibitor 67 PEGINTRON TM 67 Tacrolimus 67 Myeloma Patients 67 Augment TM 67 FOLOTYN ® 67 Tyrosine Kinase Inhibitor 67 Xcytrin R 67 ergot derivatives 67 IMiDs ® compound 67 injectable bulking agent 67 Pharmacokinetic Study 67 Catheter Ablation 67 Demonstrates Efficacy 67 Achieves Primary Endpoint 67 Vidaza ® 67 interferon beta 1a infertility 67 Immunotherapeutic 67 ocular formulation 67 Glatiramer Acetate 67 Eur J 67 Stent Restenosis 67 IND Filing 67 vapreotide acetate 67 Schizophrenia Treatment 67 Safinamide 67 novel VDA molecule 67 TRANSDUR ® 67 PEGylated anti 67 Present Preclinical Data 67 vinca alkaloid 67 CYP#A# CYP#D# 67 gefitinib Iressa 67 Mycophenolate Mofetil 67 Rheumatoid Arthritis Patients 67 Diabetic Nephropathy 66 Bepreve TM 66 Lubiprostone 66 Antiviral Activity 66 ST Segment Elevation 66 Shows Promise Against 66 CYT# potent vascular disrupting 66 Study Showed 66 Previously Treated 66 Prospective Multicenter 66 Liberte TM 66 Receives FDA Clearance 66 CT Angiography 66 Diabetic Patients 66 Pegylated Liposomal Doxorubicin 66 PROSTASCINT R 66 Efficacy Trial 66 Node Positive 66 Surgical Treatment 66 mGluR5 negative 66 J Clin 66 ODT metoclopramide HCl PEPCID 66 Drug Eluting Stents 66 Overactive Bladder 66 Advanced Melanoma 66 ™ Everolimus Eluting 66 Randomized Double Blind Placebo 66 Placebo Controlled 66 Osteoporosis Drug 66 Clolar ® 66 Myocardial Infarction Study 66 Left Ventricular Dysfunction 66 Combination Treatment 66 Aortic Valve 66 Dose Escalation 66 Successfully Treats 66 Previously Untreated 66 Pafuramidine 66 Clin Oncol 66 PKC# 66 Metastatic Prostate Cancer 66 RNAi Therapeutic 66 targeted radiotherapeutic 66 Total Knee Arthroplasty 66 Pharmaceuticals Initiates 66 Interferon Gamma 66 Diabetic Foot Ulcer 66 HepaSphere 66 Subgroup Analysis 66 Gastrointestinal Liner 66 Platinum Chromium 66 Atypical Hemolytic Uremic Syndrome 66 Microspheres 66 Pertuzumab 66 Metastatic Colorectal Cancer 66 Cannabinor 66 SABER ™ 66 cyclophosphamide methotrexate 66 Refractory Hodgkin Lymphoma 66 Monotherapy 66 Oral Formulation 66 Polymerase Inhibitor 66 Valsartan 66 Initiated Phase 66 XIENCE V Everolimus Eluting 66 Endeavor Drug Eluting 66 Irinotecan 66 NASH Huntington 66 Castration Resistant Prostate Cancer 66 Protease Inhibitor 66 Stent System 66 Skeletal Muscle 66 Study Demonstrates 66 WRX STi +# mins 66 DUROS 66 registrational Phase 66 Diabetic Neuropathy 66 bucindolol hydrochloride 66 STENT 66 sunitinib Sutent ® 66 Adjuvant Therapy 66 Allogeneic 66 Dasatinib 66 Chronic Myeloid Leukemia 66 Transcatheter 66 atypical Hemolytic Uremic Syndrome 66 FOLFOX6 chemotherapy regimen 66 aripiprazole Abilify 66 erlotinib Tarceva ® 66 Phase 1b Clinical Trial 66 IND Application 66 Naive Patients 66 Randomized Phase II 66 Advanced Renal Cell 66 Novel Compound 66 Stent Implantation 66 Oral Mucositis 66 Synthetic Peptide 66 HDAC Inhibitor 66 Aortic Stenosis 66 aneurysms AAA 66 Commences Phase 66 trastuzumab Herceptin R 66 dependent kinase inhibitor 66 Xelox 66 Randomized Trials 66 Nebulized 66 TM Drug Eluting 66 Improved Survival 66 Bare Metal Stent 66 Investigational Oral 66 ERBITUX cetuximab 66 acetonide FA 66 Multicenter Phase 66 hypertrichosis occurred 66 delivers fluocinolone acetonide FA 66 SPRYCEL ® 66 vinorelbine tartrate 66 TNF Tumor Necrosis Factor 66 Cholesterol Lowering Drug 66 Telaprevir VX 66 myelodysplastic myeloproliferative diseases 66 Personalized Immunotherapy 66 Hernia Repair 66 Acute Heart Failure 66 Reperfusion Injury 66 Patency 66 Presents Preclinical 66 Recurrent Breast Cancer 66 Nicotine Vaccine 66 dasatinib Sprycel ® 66 Prophylactic Treatment 66 Myelodysplastic Syndrome MDS 66 Transdermal Delivery 66 Melphalan 66 Phase III Clinical Trials 66 ribavirin USP 66 pralatrexate injection folate analogue 66 Vascugel 66 investigational humanized monoclonal antibody 66 unfractionated heparin UFH 66 Anti Tumor Activity 66 Postmenopausal Women 66 undergoing elective percutaneous 66 Randomized Double blind 66 Patients Suffering 66 Loceryl ® 66 Brain Metastases 66 Receives Orphan Drug 66 Orally Active 66 Drug Eluting Stent 66 Valve Replacement 66 Successfully Completes Phase 66 Microwave Ablation System 66 HCV Protease Inhibitor 66 Thoracic Endoprosthesis 65 IL# PE#QQR 65 Initiates Phase 2b 65 Investigational Drug 65 Patients Receiving 65 Fludara ® 65 irinotecan doxorubicin oxaliplatin paclitaxel 65 Angiographic 65 Onyx Pharmaceuticals Announces 65 Adjunctive Therapy 65 Treating Chronic 65 MEK Inhibitor 65 Confirmatory Phase 65 Breast Cancer Recurrence 65 intravesical infusion therapy 65 Radiofrequency Ablation 65 Clinical Efficacy 65 Improve Survival 65 fallopian tube cancers 65 Chemoradiation 65 Carcinomas 65 Is Well Tolerated 65 erlotinib Tarceva R 65 Thrombus Aspiration 65 Randomized Double Blind 65 Therapeutic Vaccine 65 Novel Mechanism 65 Dapagliflozin 65 Rheumatoid Arthritis Drug 65 Percutaneous Tibial Nerve Stimulation 65 Azacitidine 65 Colorectal Cancer Patients 65 HER2 Positive 65 Contrast Enhanced 65 PHASE III 65 Phase 2b Study 65 oral beclomethasone dipropionate 65 stent DES 65 Lung Cancer Trial 65 Investigational Agent 65 Alocrest 65 Gout Drug 65 Significantly Improved 65 Diovan Exforge Tekturna Zelnorm 65 Angiotensin Converting Enzyme 65 everolimus eluting stents 65 colesevelam HCl 65 Pivotal Trials 65 oncolytic virus therapies 65 hyperphenylalaninemia HPA due 65 brand ciclesonide HFA 65 Romidepsin 65 metastatic colorectal 65 docetaxel Taxotere ® 65 Abciximab 65 alpha 2a 65 temsirolimus Torisel 65 sunitinib Sutent 65 Factor Receptor 65 Meta Analysis 65 Refractory Angina 65 Attenuates 65 ritonavir boosted 65 Pegylated Interferon 65 dual endothelin receptor antagonist 65 Crit Rev 65 SUPPRELIN R LA 65 Anticancer Activity 65 Sirolimus eluting 65 Combination Therapy 65 oral prodrug 65 Metastatic Renal Cell Carcinoma 65 Minimally Invasive Treatment 65 CCX# B 65 Heart Transplant Recipients 65 Dual Antiplatelet Therapy 65 Topline Results 65 Clinical Trial Data 65 Less Invasive 65 Knee Osteoarthritis 65 MIVI III 65 Double Blind Placebo 65 Oral Presentations 65 Treated Patients 65 Abstract Accepted 65 monoclonal antibody IgG1 Mab 65 Myocardial Ischemia 65 Peginterferon alfa 2b 65 Lupus Nephritis 65 Chronic Hepatitis B 65 Receives Marketing Authorization 65 alfa 2a 65 Potent Antiviral Activity 65 Eculizumab 65 PROVENGE ® 65 Bone Graft 65 Alfacell proprietary ribonuclease 65 Sapacitabine 65 IMiDs ® 65 Insulin Glargine 65 INTEGRILIN R 65 Interferon beta 1a 65 ACE Inhibitors 65 2 inhibitor CYT# 65 ProChon Biotech 65 Aurora Kinase 65 Secondary Hyperparathyroidism 65 Proven Effective 65 ALN PCS 65 Cimzia certolizumab pegol 65 Antiplatelet 65 uricase 65 Novolimus 65 Small Molecule 65 Fracture Risk 65 ATRA IV 65 C1 Inhibitor 65 Thrombotic 65 ® lenalidomide 65 peripherally acting 65 Relapsed Multiple Myeloma 65 Epratuzumab 65 GW# [003] 65 Coronary Stent System 65 ThermoDox R 65 SUTENT ® 65 selective androgen receptor modulator 65 QUADRAMET R 65 Multicenter Study 65 Luteinizing Hormone Releasing Hormone 65 Statin Therapy 65 kidney urologic 65 orally inhaled migraine 65 Confirms Efficacy 65 dextromethorphan quinidine 65 Carotid Stenting 65 J Am Acad 65 R brand levalbuterol 65 endoluminal stent graft 65 Restenosis 65 Hemodialysis Patients 65 KL4 Surfactant 65 Intracranial Aneurysms 65 Advanced Prostate Cancer 65 Civacir 65 modified glutathione analog 65 Predict Risk 65 Surgical Sealant 65 Pediatric Patients 65 Primary Hypercholesterolemia 65 Intravesical 65 liposomal formulation 65 telomerase therapeutic 65 Drug Shows Promise 65 Psoriasis Drug 65 Inflammatory Markers 65 Septic Shock 65 Lenalidomide 65 Curr Opin 65 Cyclophosphamide 65 Surgical Mesh 65 Mg Uk 65 Interferon Alpha 65 AAG geldanamycin analog 65 urethral bulking agent 65 Known hypersensitivity 65 Significantly Reduces 65 Artery Disease 65 Prostate Cancer Vaccine 65 aspirin clopidogrel 65 RGOODMAN@ENQUIRER.COM 65 Slows Progression 65 Pharmacokinetics PK 65 ERATO 65 Significantly Improves 65 Tipranavir 65 Placebo Controlled Study 65 STRIDE PD 65 Express2 TM 65 Sandostatin R 65 evaluating picoplatin 65 Initiates Phase 64 Neovascularization 64 Left Ventricular 64 Proves Effective 64 NEVO 64 renal artery stenting 64 Bone Metastases 64 Sustained Efficacy 64 Dendritic Cells 64 Minimally Invasive Procedure 64 Pegloticase 64 docetaxel Taxotere R 64 Liposomal 64 Phase IIa Trial 64 platform HDL Mimetic 64 Betaferon R 64 Febuxostat 64 Phase IIa Clinical Trial 64 orally administered inhibitor 64 Multicenter 64 Advanced Colorectal Cancer 64 Kidney Transplant Recipients 64 molecular imaging radiopharmaceutical 64 Coronary Artery Bypass Graft 64 Acute Coronary Syndromes 64 IIIa inhibitor 64 Intervention Effectiveness 64 Trandolapril 64 Elderly Patients 64 FDA Clearance 64 Microplasmin 64 evaluating satraplatin 64 EnteroMedics proprietary neuroblocking technology 64 Inhaled Corticosteroids 64 Resten NG 64 Stent Coating 64 Oral Anticoagulant 64 Tocilizumab 64 eluting stent 64 Infected Patients 64 COPEGUS R 64 Hypercholesterolemia 64 Tissue Repair 64 Renal Impairment 64 includes Dideco CarboMedics 64 Posaconazole 64 Severe Asthma 64 Fixed Dose 64 Generic Version 64 Sirolimus Eluting 64 FOLFOX6 64 injectable polymer 64 Cetrorelix 64 Systemic Sclerosis 64 toenail onychomycosis 64 Localized Prostate Cancer 64 Biomarker Study 64 Zoledronic Acid 64 reslizumab 64 Preclinical Efficacy 64 pioglitazone HCl 64 THAT ARE DIFFICULT TO 64 Disease Progression 64 Trastuzumab 64 Prostate Cancer Patients 64 Golimumab 64 Pulmonary Arterial Hypertension 64 essential thrombocythemia ET 64 Biolimus A9 64 Platinol ® cisplatin 64 oral dual endothelin 64 LHRH receptor positive 64 metaglidasen 64 Cardiovasc 64 Receives Milestone Payment 64 PEGylated Fab fragment 64 Antiplatelet Therapy 64 Therapy Reduces 64 Nitazoxanide 64 coronary stent merged 64 Therapy Improves 64 Renal Cancer 64 Occlusive Disease 64 Deforolimus 64 Disease IBD 64 Inflammatory Diseases 64 oral picoplatin 64 Migraine Drug 64 Oral Cladribine 64 ADP receptor antagonist 64 J Allergy Clin 64 Endometrial Cancer 64 paclitaxel eluting 64 Non Invasive Treatment 64 Nuvelo Announces 64 Progenitor Cells 64 Endovascular Treatment 64 Sipuleucel T 64 Am J Obstet 64 Cloretazine ® 64 IN PATIENTS WITH 64 Randomised 64 V Everolimus Eluting Coronary 64 monoclonal antibody conjugated 64 J Consult Clin 64 Pivotal Phase II 64 5 Fluorouracil 64 Regenerative Cell 64 Myelodysplastic Syndromes 64 PHX# 64 Drug Fails 64 multicenter randomized controlled 64 Dupuytren Contracture 64 Anthracycline 64 Embolization 64 Moxifloxacin 64 Combination Clinical Trial 64 Fungal Infections 64 Phospholipase A2 64 STELARA TM 64 Prospective Randomized Trial 64 BENICAR 64 Val HeFT 64 Nat Clin Pract 64 Vitrasert R 64 J Shoulder Elbow 64 Intracoronary 64 Anti Inflammatory Drug 64 Kidney Function 64 Anticancer Agent 64 Squalamine 64 refractory chronic lymphocytic 64 Osteoporosis Drugs 64 fondaparinux sodium 64 Myocardial Perfusion Imaging 64 metastatic GIST 64 Arno Therapeutics 64 TRX1 64 Triapine 64 Effectively Treats 64 Announces Tentative Approval 64 DNA intercalator 64 Preclinical Models 64 Adenoma Prevention 64 Prognostic Value 64 Clinical Evaluation 64 Fulvestrant 64 FUSILEV enhances 64 miconazole Lauriad ® 64 Observational Study 64 Plus Ribavirin 64 Tesetaxel 64 product platforms AZX# 64 Blood Pressure Drug 64 Cilostazol 64 cardiac resynchronisation therapy 64 Begins Dosing 64 Prodrug 64 Xeloda ® 64 Therapeutic Efficacy 64 EURIDIS 64 Hematological Malignancies 64 Cutaneous T 64 Dose Ranging 64 Resection 64 Maleate 64 Shows Statistically Significant 64 Robotic Assisted 64 Tigecycline 64 R roscovitine CDK cyclin 64 investigational oral inhibitor 64 Adenoma 64 Sevelamer 64 Initiate Phase II 64 Increased Mortality 64 Neurosurg 64 Immunomedics Announces 64 Positive Opinion 64 Tiotropium 64 IV Busulfex 64 Int J Obes Relat 64 herpetic keratitis 64 Enrolling Patients 64 HuMax EGFr 64 Endologix Powerlink System 64 PRECISE 64 Ridaforolimus 64 pegylated liposomal doxorubicin 64 lexidronam injection PROSTASCINT 64 Receives Positive Opinion 64 Clinical Study 64 Lowers Risk 64 Metabolic Efficiency 64 PNP inhibitor 64 Osteoporosis Treatment 64 Neulasta R 64 dihydrochloride 64 Receives CE Marking 64 Lymph Node 64 TLK# 64 Bevacizumab 64 pan histone deacetylase 64 Cloretazine 64 Biphasic 64 PEGASYS ® 64 Varespladib 64 Hematopoietic 64 Lung Cancer Patients 64 Prenatal Diagnosis 64 RE MODEL 64 Dural Regeneration Matrix 64 Anti Bacterial Envelope 64 Solution XOPENEX HFA 64 Relapsed Refractory 64 Mouse Model 64 Benign Prostatic Hyperplasia 64 Reports Preclinical Data 64 Kinase Inhibitors 64 Lung Cancer Drug 64 Vildagliptin 64 multicenter Phase III 64 Radical Prostatectomy 64 virus HCV protease inhibitor 64 Bioartificial Liver 64 Myoblast 63 Thrombectomy System 63 cinacalcet 63 Bare Metal Stents 63 INDUSTRY ASSESSMENTS 63 Xanafide 63 IN.PACT Falcon 63 Omacetaxine 63 Mitral Valve Repair 63 biomodulator 63 Vascular Disrupting Agent 63 Gemzar ® 63 vitro pharmacology 63 Drug Eluting Stent System 63 Announces Poster Presentations 63 FEMALES SHOULD BE ADVISED 63 Oral Insulin 63 Inflammatory Arthritis 63 Replacement Therapy 63 Cardiac Allograft Rejection 63 Files Investigational 63 Injectable Bone Graft 63 Sanvar R 63 Late Breaker 63 Novel Antibiotic 63 Aortic Aneurysm 63 Myocet 63 Adult Stem Cell Therapy 63 Camptosar ® 63 Adenoviral 63 更多 的 63 Study Shows Significant 63 Orthop Surg 63 POLYSHIELD ® POLYCLEAR ® 63 Unstable Angina 63 cetuximab Erbitux ® 63 MKC# 63 Diabetic Macular Edema DME 63 LibiGel ® 63 AVASTIN 63 Epirubicin 63 humanized monoclonal 63 Therapy Evaluation 63 Tanespimycin 63 Plaque Psoriasis 63 Receptor Antagonist 63 sorafenib tablets 63 pain palliation 63 Hepatitis C Genotype 63 Non Alcoholic Steatohepatitis 63 Clinical Study Shows 63 Treatment Naïve Patients 63 PROMUS TM 63 Autologous 63 myocardial infarction ventricular fibrillation 63 Targeted Therapy 63 treating abdominal aortic 63 Cardiol 63 candidates Azedra TM 63 Nitinol Stent 63 Inhalation Solution 63 Tumor Growth 63 Absorbable 63 R bisoprolol Euthyrox 63 Liver Failure 63 Appears Safe 63 Smooth Muscle 63 Cardiac Resynchronization Therapy 63 Shows Efficacy 63 Neuroprotection 63 Cotavance 63 oral proteasome inhibitor 63 Pioglitazone 63 Ophena 63 Platinol ® 63 Endurant 63 Obese Patients 63 Oral Calcitonin 63 GOUT 63 Rotavirus Vaccine 63 lucinactant 63 Hormone Receptor Positive 63 Nucleoside 63 Kepivance 63 Venous Thromboembolism 63 Peripheral Stent 63 metastatic neuroendocrine tumors 63 Dose Response 63 BioSante Pharmaceuticals Announces 63 Pharmacodynamics 63 Juvenile Idiopathic Arthritis 63 allosteric modulator NAM 63 induced macular edema 63 Evo +# mins 63 treat benign prostatic 63 Drug Combo 63 R brand arformoterol 63 Bone Mineral Density 63 Immunosuppression 63 Tolerability 63 Orally administered 63 Spectrum Pharmaceuticals Announces 63 Neovascular Age Related Macular 63 C Reactive Protein 63 capecitabine Xeloda 63 Myelofibrosis 63 Iluvien ® 63 dopamine D2 63 CHEAP ONLINE PHARMACY LOW 63 Recurrent Glioblastoma 63 Lung Cancers 63 Novel Therapeutic 63 Cardiovascular Events 63 Epidermal Growth Factor Receptor 63 Monoclonal 63 Vascular Grafts 63 Hematological 63 Brentuximab Vedotin SGN 63 rusalatide acetate 63 Gastrointestinal Stromal Tumors 63 Patient Enrolment 63 MR Angiography 63 Oncologic 63 Reduces Pain 63 Lupus Drug 63 Solazed TM 63 Fluorouracil 63 relapsed MM 63 Lowers Blood Pressure 63 Peripheral Arterial 63 Demonstrate Significant 63 Chronic Sinusitis 63 Temsirolimus 63 Androxal TM 63 Hepatocellular 63 plus GP IIb 63 Diabetic Foot Ulcers 63 Granulocyte Colony Stimulating Factor 63 Sangamo BioSciences Announces 63 Central Retinal Vein 63 Antithrombin 63 Neurol 63 Stereotactic Body Radiation Therapy 63 Seliciclib CYC# 63 Acute Myocardial 63 Ovarian Cancer Patients 63 gemcitabine Gemzar 63 sargramostim 63 YONDELIS 63 HQK 63 Treatment Naive Patients 63 azilsartan medoxomil 63 R bendamustine hydrochloride 63 paclitaxel Taxol ® 63 See WARNINGS 63 ® chorionic gonadotropin 63 Immunogenicity 63 #-# Full Text 63 BENICAR HCT 63 Corneal Transplant 63 Patent Covering 63 Levels Linked 63 Peptic Ulcer 63 LymphoStat B belimumab 63 Demonstrates Potential 63 Soft Tissue Sarcoma 63 Adenoscan R 63 Immunomodulatory 63 Ondansetron Injection USP 63 CARDIOVASCULAR 63 Ceflatonin R 63 Hepatic Encephalopathy 63 VICTOR E3 63 Intracerebral 63 Telbivudine 63 IMiDs R 63 AEG# 63 Ozarelix 63 Renal Insufficiency 63 Testosterone Gel 63 Malignant Melanoma 63 Pulmonary Valve 63 Develops Novel 63 Breast Cancer Cells 63 Alfimeprase 63 R Paclitaxel Eluting 63 mechanical thrombectomy